Advertisement
Recommendations have been developed for use of anesthesia during the COVID-19 pandemic

Recommendations Developed for Anesthesia Use During COVID-19

0
Risk for postop complications lower with regional anesthesia; odds of aerosol generation up with general anesthesia
An estimated 45.4 percent of U.S. adults may have an increased risk for COVID-19 complications due to chronic conditions

45.4 Percent of U.S. Adults at Risk for Complications With COVID-19

0
These adults may be at increased risk due to existing chronic conditions including CVD, diabetes, HTN
COVID-19 is associated with a high rate of pulmonary embolism

High Rate of Pulmonary Embolism Found for Patients With COVID-19

0
Two studies demonstrate high rate of PE; 100 percent sensitivity for PE seen for D-dimer level > 2,660 µg/L
High-dosage chloroquine diphosphate has potential safety hazards when used as adjunctive therapy for patients hospitalized with severe COVID-19

Adding High-Dose Chloroquine Not Advised for Severe COVID-19

0
High-dose versus low-dose group had higher lethality until day 13, more instances of QTc interval >500 ms
Persons aged 60 to 69 years with COVID-19 are the most commonly hospitalized

Patients Aged 60 to 69 Most Often Hospitalized With COVID-19

0
At California KPNC hospitals, most common age group hospitalized, admitted to ICU was those aged 60 to 69 years
Health care organizations are facing hard financial decisions amid the COVID-19 pandemic

David Shulkin, M.D., on COVID-19 Financial Consequences for Health Care System

0
Shulkin, ninth secretary for Veterans Affairs, estimates health care provider revenue down about $500 billion
A single symptomatic COVID-19 infection results in direct medical costs of $3

Direct Medical Costs of COVID-19 Infection Are Considerable

0
Costs could vary from $163.4 to $654.0 billion for 20 to 80 percent of U.S. population infected, respectively
In an international expert consensus statement

Recommendations Issued for Imaging Use in Pediatric COVID-19

0
Recommendations applicable for mild COVID-19, moderate-severe COVID-19 with, without resource constraints
Acute respiratory distress syndrome due to COVID-19 is associated with neurologic features

Neurologic Features Tied to ARDS in Severe COVID-19 Described

0
Unclear whether critical illness, medication, infection itself may cause encephalopathy, agitation, confusion
Inconclusive findings from a study investigating the antiviral drug remdesivir as a treatment for COVID-19 were posted to the World Health Organization website "prematurely

Premature Posting of Remdesivir Findings Were ‘Inconclusive’

0
Due to low enrollment, study was 'underpowered to enable statistically meaningful conclusions'